-
1
-
-
0035691566
-
Preemptive analgesia I: Physiological pathways and pharmacological modalities
-
Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anaesth 2001; 48: 1000-10.
-
(2001)
Can J Anaesth
, vol.48
, pp. 1000-1010
-
-
Kelly, D.J.1
Ahmad, M.2
Brull, S.J.3
-
2
-
-
0033775731
-
Preemptive analgesia
-
Kissin I. Preemptive analgesia. Anesthesiology 2000; 93: 1138-43.
-
(2000)
Anesthesiology
, vol.93
, pp. 1138-1143
-
-
Kissin, I.1
-
3
-
-
0027166359
-
Preemptive analgesia: Treating postoperative pain by preventing the establishment of central sensitization
-
Woolf CJ, Chong MS. Preemptive analgesia: treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993; 77: 362-79.
-
(1993)
Anesth Analg
, vol.77
, pp. 362-379
-
-
Woolf, C.J.1
Chong, M.S.2
-
4
-
-
3042587914
-
Preemptive meloxicarn for postoperative pain relief after abdominal hysterectomy
-
Akarsu T, Karaman S, Akercan F, Kazandi M, Yucebilgin MS, Firat V. Preemptive meloxicarn for postoperative pain relief after abdominal hysterectomy. Clin Exp Obst Gynecol 2004; 31: 133-6.
-
(2004)
Clin Exp Obst Gynecol
, vol.31
, pp. 133-136
-
-
Akarsu, T.1
Karaman, S.2
Akercan, F.3
Kazandi, M.4
Yucebilgin, M.S.5
Firat, V.6
-
5
-
-
0021014399
-
Evidence for a central component of post-injury pain hypersensitivity
-
Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983; 306: 686-8.
-
(1983)
Nature
, vol.306
, pp. 686-688
-
-
Woolf, C.J.1
-
6
-
-
0035569212
-
Pre-emptive analgesia II: Recent advances and current trends
-
Kelly DJ, Ahmad M, Brull SJ. Pre-emptive analgesia II: recent advances and current trends. Can J Anaesth 2001; 48: 1091-101.
-
(2001)
Can J Anaesth
, vol.48
, pp. 1091-1101
-
-
Kelly, D.J.1
Ahmad, M.2
Brull, S.J.3
-
7
-
-
0030878425
-
Pre-emptive epidural morphine for postoperative pain relief after lumbar laminectomy
-
Kundra P, Gurnani A, Bhattacharya A. Pre-emptive epidural morphine for postoperative pain relief after lumbar laminectomy. Anesth Analg 1997; 85: 135-8.
-
(1997)
Anesth Analg
, vol.85
, pp. 135-138
-
-
Kundra, P.1
Gurnani, A.2
Bhattacharya, A.3
-
8
-
-
0036138463
-
The effects of three different analgesia techniques on lon-term post-thoracotomy pain
-
Senturk M, Ozcan PF, Talu GK, Kiyan E, Camci E, Ozyalcin S et al. The effects of three different analgesia techniques on lon-term post-thoracotomy pain. Anesth Analg 2002; 94: 11-15.
-
(2002)
Anesth Analg
, vol.94
, pp. 11-15
-
-
Senturk, M.1
Ozcan, P.F.2
Talu, G.K.3
Kiyan, E.4
Camci, E.5
Ozyalcin, S.6
-
9
-
-
0023571137
-
The morphine sparing effects of diclofenac sodium following abdominal surgery
-
Hodsman NB, Burns J, Blyth A, Kenny GN, McArdle CS, Rotman H. The morphine sparing effects of diclofenac sodium following abdominal surgery. Anaesthesia 1987; 42: 1005-8.
-
(1987)
Anaesthesia
, vol.42
, pp. 1005-1008
-
-
Hodsman, N.B.1
Burns, J.2
Blyth, A.3
Kenny, G.N.4
McArdle, C.S.5
Rotman, H.6
-
10
-
-
0031047214
-
Rectal diclofenac sodium analgesia after abdominal hysterectomy
-
Scott RM, Jennings PN. Rectal diclofenac sodium analgesia after abdominal hysterectomy. Aust NZJ Obstet Gynecol 1997; 37: 112-4.
-
(1997)
Aust NZJ Obstet Gynecol
, vol.37
, pp. 112-114
-
-
Scott, R.M.1
Jennings, P.N.2
-
11
-
-
0028044609
-
Towards a better aspirin
-
Vane J. Towards a better aspirin. Nature 1994; 367: 215-6.
-
(1994)
Nature
, vol.367
, pp. 215-216
-
-
Vane, J.1
-
12
-
-
0027480087
-
Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs
-
Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610-4.
-
(1993)
J Biol Chem
, vol.268
, pp. 6610-6614
-
-
Meade, E.A.1
Smith, W.L.2
DeWitt, D.L.3
-
13
-
-
0028954284
-
The human 180-kDa receptor for secretory phospholipases A2:molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization
-
Ancian P, Lambeau G, Mattei MG, Lazdunski M. The human 180-kDa receptor for secretory phospholipases A2:molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. J Biol Chem 1995; 270: 8963-70.
-
(1995)
J Biol Chem
, vol.270
, pp. 8963-8970
-
-
Ancian, P.1
Lambeau, G.2
Mattei, M.G.3
Lazdunski, M.4
-
15
-
-
0032795598
-
Analgesic effect of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: A randomized control trial
-
Morrison BW, Christensen S, Yuan W, Brown J, Amlani S, Seidenberg B. Analgesic effect of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized control trial. Clin Ther 1999; 21: 943-53.
-
(1999)
Clin Ther
, vol.21
, pp. 943-953
-
-
Morrison, B.W.1
Christensen, S.2
Yuan, W.3
Brown, J.4
Amlani, S.5
Seidenberg, B.6
-
17
-
-
0034858635
-
The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered, preoperatively
-
Desjardins PJ, Grossman EH, Kuss ME, Talwalker S, Dhadda S, Baum D, et al. The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered, preoperatively. Anesth Analg 2001; 93: 721-7.
-
(2001)
Anesth Analg
, vol.93
, pp. 721-727
-
-
Desjardins, P.J.1
Grossman, E.H.2
Kuss, M.E.3
Talwalker, S.4
Dhadda, S.5
Baum, D.6
-
18
-
-
0033031331
-
COX-2 inhibitors
-
Hawkey CJ. COX-2 inhibitors. Lancet 1999; 353: 307-14.
-
(1999)
Lancet
, vol.353
, pp. 307-314
-
-
Hawkey, C.J.1
-
19
-
-
0029867761
-
Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2
-
Engelhardt G. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol 1996; 35: 4-12.
-
(1996)
Br J Rheumatol
, vol.35
, pp. 4-12
-
-
Engelhardt, G.1
-
20
-
-
0032994274
-
Clinical pharmacokinetics of meloxicam
-
Davies NM, Skjodt NM. Clinical pharmacokinetics of meloxicam. Clin Phamacokinet 1999; 36: 115-26.
-
(1999)
Clin Phamacokinet
, vol.36
, pp. 115-126
-
-
Davies, N.M.1
Skjodt, N.M.2
-
22
-
-
0030024644
-
Pharmacokinetics and tolerability of meloxicam after i.m. administration
-
Narjes H, Turck D, Busch U, Heinzel G, Nehmitz G. Pharmacokinetics and tolerability of meloxicam after i.m. administration. Br J Clin Pharmacol 1996; 41: 135-9.
-
(1996)
Br J Clin Pharmacol
, vol.41
, pp. 135-139
-
-
Narjes, H.1
Turck, D.2
Busch, U.3
Heinzel, G.4
Nehmitz, G.5
-
23
-
-
0034991101
-
Safety and efficacy of preoperative administration of meloxicam; compared with that of ketoprofen and butorphanol in dogs undergoing abdominal surgery
-
Mathews KA, Pettifer G, Foster R, Mc Donell W. Safety and efficacy of preoperative administration of meloxicam; compared with that of ketoprofen and butorphanol in dogs undergoing abdominal surgery. Am J Vet Res 2001; 62: 882-8.
-
(2001)
Am J Vet Res
, vol.62
, pp. 882-888
-
-
Mathews, K.A.1
Pettifer, G.2
Foster, R.3
Mc Donell, W.4
-
24
-
-
0032851480
-
A randomized trial comparing the effect of rofecoxib, a cyclooxygenase-2 inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
-
Laine L, Harper S, Simon T, Bath R, Johanson J, Schwartz H et al. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase-2 inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology 1999; 117: 776-83.
-
(1999)
Gastroenterology
, vol.117
, pp. 776-783
-
-
Laine, L.1
Harper, S.2
Simon, T.3
Bath, R.4
Johanson, J.5
Schwartz, H.6
-
25
-
-
0033601089
-
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized control trail
-
Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized control trail. JAMA 1999; 282: 1921-8.
-
(1999)
JAMA
, vol.282
, pp. 1921-1928
-
-
Simon, L.S.1
Weaver, A.L.2
Graham, D.Y.3
Kivitz, A.J.4
Lipsky, P.E.5
Hubbard, R.C.6
-
26
-
-
0031685519
-
Gastrointestinal tolerability of the COX-2 inhibitor, meloxicam in osteoarthritis patients: The meloxicam large scale international study safety assessment
-
Hawkey C, Kahan A, Steinbruck K, Alegre C, Baumelou E, Begaud B et al. Gastrointestinal tolerability of the COX-2 inhibitor, meloxicam in osteoarthritis patients: the meloxicam large scale international study safety assessment. Br J Rheumatol 1998; 37: 937-45.
-
(1998)
Br J Rheumatol
, vol.37
, pp. 937-945
-
-
Hawkey, C.1
Kahan, A.2
Steinbruck, K.3
Alegre, C.4
Baumelou, E.5
Begaud, B.6
-
27
-
-
0034078924
-
The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis b) fresh human gastric mucosa
-
Tavares IA. The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis b) fresh human gastric mucosa. Aliment Pharmacol Ther 2000; 14: 795-9.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 795-799
-
-
Tavares, I.A.1
-
28
-
-
0033869073
-
Characterisation of lipopolysaccaride-induced emesis in conscious piglets: Effects of cervical vagotomy, cyclooxygenase inhibitors and 5-HT(3) receptor antagonism
-
Girod V, Bouvier M, Grelot L. Characterisation of lipopolysaccaride-induced emesis in conscious piglets: effects of cervical vagotomy, cyclooxygenase inhibitors and 5-HT(3) receptor antagonism. Neuropharmacology 2000; 39: 2329-35,
-
(2000)
Neuropharmacology
, vol.39
, pp. 2329-2335
-
-
Girod, V.1
Bouvier, M.2
Grelot, L.3
-
29
-
-
0036100771
-
Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis
-
Knijff-Dutmer EAJ, Kalsbeek-Batenburg EM, Koerts J, van de Laar MAFJ. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis. Rheumatology 2002; 41: 458-61.
-
(2002)
Rheumatology
, vol.41
, pp. 458-461
-
-
Knijff-Dutmer, E.A.J.1
Kalsbeek-Batenburg, E.M.2
Koerts, J.3
van de Laar, M.A.F.J.4
-
30
-
-
0032742778
-
Meloxicam, 15 mg/day, spares platelet function in healty volunteers
-
Meijer A, Vollard H, Metz M, Verbruggen B, Thomas C, Novakova I. Meloxicam, 15 mg/day, spares platelet function in healty volunteers. Clin Pharmacol Ther 1999; 66: 425-30.
-
(1999)
Clin Pharmacol Ther
, vol.66
, pp. 425-430
-
-
Meijer, A.1
Vollard, H.2
Metz, M.3
Verbruggen, B.4
Thomas, C.5
Novakova, I.6
-
31
-
-
0025816709
-
Non-steroidal anti-inflammatory drugs: Rationale for use in severe postoperative pain
-
Dahl JB, Kehlet H. Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain. Br J Anaesth 1991; 66: 703-12.
-
(1991)
Br J Anaesth
, vol.66
, pp. 703-712
-
-
Dahl, J.B.1
Kehlet, H.2
-
32
-
-
0033965878
-
Effect of meloxicam on postoperative pain after abdominal hysteretomy
-
Thompson JP, Sharpe P, Kaini S, Owen-Smith O. Effect of meloxicam on postoperative pain after abdominal hysteretomy. Br J Anaesth 2000: 84: 151-4.
-
(2000)
Br J Anaesth
, vol.84
, pp. 151-154
-
-
Thompson, J.P.1
Sharpe, P.2
Kaini, S.3
Owen-Smith, O.4
-
33
-
-
0036139747
-
Pre-emptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery
-
Reuben SS, Bhopatkar S, Maciolek H, Joshi W, Sklar J. Pre-emptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 2002; 94: 55-9.
-
(2002)
Anesth Analg
, vol.94
, pp. 55-59
-
-
Reuben, S.S.1
Bhopatkar, S.2
Maciolek, H.3
Joshi, W.4
Sklar, J.5
-
34
-
-
0029316479
-
The recurrence rate in hernia surgery: How important is it?
-
Rutkow IM. The recurrence rate in hernia surgery: How important is it? Arch Surg 1995; 130: 575-6.
-
(1995)
Arch Surg
, vol.130
, pp. 575-576
-
-
Rutkow, I.M.1
|